Prognostic impact of right ventricular function affected by pulmonary hypertension in hospitalized heart failure patients
- PMID: 34933800
- DOI: 10.1016/j.jjcc.2021.10.008
Prognostic impact of right ventricular function affected by pulmonary hypertension in hospitalized heart failure patients
Abstract
Background: Pulmonary hypertension (PH) may affect right ventricular (RV) function; however, the prognostic implications of RV function in patients with heart failure and PH remain unclear. We aimed to investigate the impact of RV function on the prognosis of hospitalized heart failure patients with and without PH.
Methods: This observational study initially included 1,349 consecutive hospitalized heart failure patients. After excluding patients who died in hospital, whose left ventricular (LV) function was preserved, and whose echocardiography data were incomplete, 573 patients with heart failure and reduced LV ejection fractions (HFrEF) were analyzed. The patients were grouped according to RV dysfunction that was defined as an RV-tissue Doppler imaging systolic velocity (RV-TDI s') of ≤9.5 cm/s. The primary endpoint was a composite of cardiovascular death and rehospitalization as a consequence of heart failure.
Results: Overall, the patients with reduced RV function had significantly higher event rates than those with preserved RV function (log-rank test p = 0.01). This prognostic impact was observed in the patients with PH (p = 0.001) and was not evident among the patients without PH (p = 0.39). In the patients with PH, reduced RV function independently predicted the prognosis after adjusting for the covariates (adjusted hazard ratio: 3.12; 95% confidence interval: 1.44 to 6.73).
Conclusion: RV dysfunction that was estimated during hospitalization using the RV-TDI s', which is a simply determined index, may predict clinical outcomes in hospitalized patients with HFrEF and PH after discharge, but not in those without PH.
Keywords: Heart failure; Right ventricular function; Tissue doppler imaging.
Copyright © 2021. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest There are no conflicts of interest to declare. This manuscript has not been published or presented elsewhere in part or in entirety, and is not under consideration by another journal. All of the study participants provided informed consent, and the study design was approved by the appropriate ethics review board.
Publication types
MeSH terms
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Medical
